Literature DB >> 25006411

First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive disease.

M Patricia George1, Enrico M Novelli1, Norihisa Shigemura1, Marc A Simon1, Brian Feingold2, Lakshmanan Krishnamurti2, Matthew R Morrell1, Cynthia G Gries1, Syed Haider1, Bruce A Johnson1, Maria M Crespo1, Jay K Bhama1, Christian Bermudez1, Samuel A Yousem1, Yoshiya Toyoda3, Hunter C Champion1, Joseph M Pilewski1, Mark T Gladwin1.   

Abstract

Little is known about the use of lung transplantation in the management of sickle cell disease-associated pulmonary arterial hypertension (SCD-PAH). We present clinical and pathological data and report the first successful outcome of bilateral lung transplantation in a patient with severe SCD-PAH and pulmonary veno-occlusive disease (PVOD). We discuss the complexities of multidisciplinary planning and management of lung transplantation in patients with SCD-associated pulmonary vascular complications. This case reports the first documented successful lung transplant and first case of PVOD in a patient with SCD-PAH.

Entities:  

Keywords:  lung transplantation; pulmonary arterial hypertension; pulmonary veno-occlusive disease; sickle cell disease

Year:  2013        PMID： 25006411      PMCID： PMC4070828          DOI： 10.1086/674749

Source DB:  PubMed          Journal:  Pulm Circ        ISSN： 2045-8932            Impact factor:   3.017


  33 in total

1.  Renal transplantation in end-stage sickle cell nephropathy.

Authors:  A O Ojo; T C Govaerts; R L Schmouder; A B Leichtman; S F Leavey; R A Wolfe; P J Held; F K Port; L Y Agodoa
Journal:  Transplantation       Date:  1999-01-27       Impact factor: 4.939

2.  Prevalence, risk factors and mortality of pulmonary hypertension defined by right heart catheterization in patients with sickle cell disease.

Authors:  Mark T Gladwin
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

3.  The case. Allograft dysfunction in a patient with sickle cell disease.

Authors:  Edward J O'Rourke; Christopher M Laing; Aakif U Khan; R Hussain; Richard A Standish; John R Buscombe; Andrew J W Hilson; Mark Harber
Journal:  Kidney Int       Date:  2008-11       Impact factor: 10.612

4.  The conjunctival sickling sign, hemoglobin S, and irreversibly sickled erythrocytes.

Authors:  K C Nagpal; G K Asdourian; M H Goldbaum; M Raichand; M F Goldberg
Journal:  Arch Ophthalmol       Date:  1977-05

5.  Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.

Authors:  S T Miller; E Wright; M Abboud; B Berman; B Files; C D Scher; L Styles; R J Adams
Journal:  J Pediatr       Date:  2001-12       Impact factor: 4.406

6.  Open heart surgery in patients with sickle cell hemoglobinopathy.

Authors:  Sajjad M Yousafzai; Murat Ugurlucan; Omar A Al Radhwan; Amal L Al Otaibi; Charles C Canver
Journal:  Circulation       Date:  2009-12-21       Impact factor: 29.690

7.  Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.

Authors:  Vandana Sachdev; Gregory J Kato; J Simon R Gibbs; Robyn J Barst; Roberto F Machado; Mehdi Nouraie; Kathryn L Hassell; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Enrico M Novelli; Reda E Girgis; Claudia R Morris; Erika Berman Rosenzweig; David B Badesch; Sophie Lanzkron; Oswaldo L Castro; James G Taylor; Hwaida Hannoush; Jonathan C Goldsmith; Mark T Gladwin; Victor R Gordeuk
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

Review 8.  Preoperative blood transfusions for sickle cell disease.

Authors:  Ceri Hirst; Lorna Williamson
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

9.  Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.

Authors:  Roberto F Machado; Robyn J Barst; Nancy A Yovetich; Kathryn L Hassell; Gregory J Kato; Victor R Gordeuk; J Simon R Gibbs; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Reda E Girgis; Claudia R Morris; Erika B Rosenzweig; David B Badesch; Sophie Lanzkron; Onyinye Onyekwere; Oswaldo L Castro; Vandana Sachdev; Myron A Waclawiw; Rob Woolson; Jonathan C Goldsmith; Mark T Gladwin
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

10.  The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

Authors:  Ersi Voskaridou; Dimitrios Christoulas; Antonios Bilalis; Eleni Plata; Konstantinos Varvagiannis; George Stamatopoulos; Klio Sinopoulou; Aggeliki Balassopoulou; Dimitris Loukopoulos; Evangelos Terpos
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113
View more
  4 in total

Review 1.  Pathophysiology and treatment of pulmonary hypertension in sickle cell disease.

Authors:  Victor R Gordeuk; Oswaldo L Castro; Roberto F Machado
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

2.  Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.

Authors:  Enrico M Novelli; Lynda Little-Ihrig; Heather E Knupp; Natasha M Rogers; Mingyi Yao; Jeffrey J Baust; Daniel Meijles; Claudette M St Croix; Mark A Ross; Patrick J Pagano; Evan R DeVallance; George Miles; Karin P Potoka; Jeffrey S Isenberg; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

Review 3.  Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease.

Authors:  Hitomi Hosoya; Jeffrey Levine; Peter Abt; David Henry; David L Porter; Saar Gill
Journal:  Blood Adv       Date:  2018-03-13

4.  Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

Authors:  Natasha M Rogers; Mingyi Yao; John Sembrat; M Patricia George; Heather Knupp; Mark Ross; Maryam Sharifi-Sanjani; Jadranka Milosevic; Claudette St Croix; Revathi Rajkumar; Maria G Frid; Kendall S Hunter; Luciano Mazzaro; Enrico M Novelli; Kurt R Stenmark; Mark T Gladwin; Ferhaan Ahmad; Hunter C Champion; Jeffrey S Isenberg
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.